FindTrial
Sign In

Radiomics-based multimodal prognosis prediction model for idiopathic pulmonary interstitial fibrosis and its pathophysiological mechanism were studied

Radiomics-based multimodal prognosis prediction model for idiopathic pulmonary interstitial fibrosis and its pathophysiological mechanism were studied

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099465
Enrollment
Unknown
Registered
2025-03-24
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis(IPF)

Interventions

Greater than median survival group:None
Less than median survival group:None

Sponsors

Gansu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients meeting the diagnostic criteria for idiopathic pulmonary fibrosis (IPF) established by the American Thoracic Society (ATS) and the European Respiratory Society (ERS), with accessible follow-up imaging and pathological tissue data, and who have signed informed consent, will be included as study subjects.

Exclusion criteria

Exclusion criteria: History of severe pulmonary comorbidities (e.g., lung cancer, severe bronchiectasis), other systemic diseases (e.g., malignancies, advanced cardiac disease), or inability to comply with follow-up requirements.

Design outcomes

Primary

MeasureTime frame
Lung function;Chest CT index;—

Secondary

MeasureTime frame
Changes in the expression of fibrosis-related proteins;Dynamic changes in systemic metabolites during fibrosis;—

Countries

China

Contacts

Public ContactXiaojun Wang

Gansu Provincial People's Hospital

wangxiaojun_work@outlook.com+86 182 9832 8910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026